To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

BioChaperone insulin lispro

Injection at t0,or t+15 minutes or t-15minutes with test meal

DRUG

Humalog®

Injection at t0,or t+15 minutes or t-15minutes with test meal

Trial Locations (1)

Profil GmbH, Neuss